BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Genetown

  Matthew Riordan Speaks at Market Access and Launch Excellence Summit 2011 in Berlin, Germany

  June 1, 2011

   · 

  3 min read
• Deals

  Myriant Technologies LLC Files for $125 Million IPO

  June 1, 2011

   · 

  1 min read
• Genetown

  AB SCIEX to Unveil New Technology and Showcase Groundbreaking Customer Success at ASMS 2011

  June 1, 2011

   · 

  1 min read
• Policy

  FDA Expectations Explained to Medical Device Manufacturers

  June 1, 2011

   · 

  1 min read
• Esperance Pharmaceuticals, Inc. Completes $7.5 Million Series B Financing

  June 1, 2011

   · 

  3 min read
• Business

  Tuberculosis Expert Joins Oxford Immunotec Limited as Senior Scientific Advisor

  June 1, 2011

   · 

  3 min read
• Job Trends

  Changes in Sanofi (France) Reporting Structure Triggers Layoff Fears

  June 1, 2011

   · 

  1 min read
• Drug Development

  Eisai Inc.: Phase II Study Results Showed Eisai’s Lenvatinib (E7080) Demonstrated an Objective Response Rate of 59% in Radioiodine (RAI)-Refractory Differentiated Thyroid Cancer

  June 1, 2011

   · 

  1 min read
• Genetown

  Covidien to Present at Goldman, Sachs & Co. Conference

  June 1, 2011

   · 

  1 min read
• Policy

  Repligen Corporation Concludes Pre-NDA Meeting with FDA for RG1068

  June 1, 2011

   · 

  1 min read